| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-06 |